Search

Shohreh Shahabi Phones & Addresses

  • Pound Ridge, NY
  • New York, NY
  • Chicago, IL
  • 578 Whitney Ave, New Haven, CT 06511 (203) 789-1950
  • 578 Whitney Ave #M2, New Haven, CT 06511 (203) 789-1950
  • 32 Highland St, New Haven, CT 06511 (203) 789-1950
  • 3411 Wayne Ave, Bronx, NY 10467 (718) 654-2931
  • Katonah, NY

Work

Company: DOPS Gynecologic Oncology, Advanced Pelvic Surgery, Robotics and Comprehensive Hereditary Tumor Cent Address: 24 Hospital Ave, Danbury, CT 06810

Education

School / High School: Universite Libre De Bruxelles

Skills

Medical Education • Clinical Research • Gynecologic Oncology • Clinical Trials • Gynecology • Board Certified • Cancer • Healthcare • Medical Research • Da Vinci • Female Cancer • Davinci • Hospitals • Cancer Research • Ovarian Cancer • Translational Research • Public Health • Medicine • Surgery • Healthcare Management • Obstetrics • Internal Medicine • Healthcare Information Technology

Languages

English

Awards

Healthgrades Honor Roll

Ranks

Certificate: Obstetrics & Gynecology, 2007

Images

Industries

Hospital & Health Care

Specialities

Gynecologic Oncology

Professional Records

Medicine Doctors

Shohreh Shahabi Photo 1

Dr. Shohreh Shahabi, Danbury CT - MD (Doctor of Medicine)

View page
Specialties:
Gynecologic Oncology
Address:
DOPS Gynecologic Oncology, Advanced Pelvic Surgery, Robotics and Comprehensive Hereditary Tumor Cent
24 Hospital Ave, Danbury, CT 06810
Procedures:
Bowel Resections
Endometriosis
Gynecologic Surgery
Gynecological Oncology Surgery
Hysterectomy
Laparoscopic Surgery
Ovarian Cysts
Pelvic Pain
Pelvic Prolapse
Pelvic Surgery
Robotic Surgery-Da Vinci
Conditions:
Cervical Cancer
Endometrial Cancer
Endometriosis
Fallopian Tube Cancer
Gestational Trophoblastic Tumor
Gynecologic Cancer
Gynecologic Malignancies
Gynecologic Surgery
Hysterectomy
Laparoscopic Surgery
Ovarian Cysts
Pelvic Pain
Pelvic Prolapse
Peritoneum Cancer
Uterine Leiomyoma
Vaginal Cancer
Vulvar Cancer
Certifications:
Obstetrics & Gynecology, 2007
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
DOPS Gynecologic Oncology, Advanced Pelvic Surgery, Robotics and Comprehensive Hereditary Tumor Cent
24 Hospital Ave, Danbury, CT 06810

Danbury Hospital
24 Hospital Avenue, Danbury, CT 06810
Philosophy:
Dr. Shahabi is the Chair, Department of Obstetrics, Gynecology and Reproductive Biology and the Chair of the Reproductive Tumor Biology Research Laboratory at The Danbury Hospital Research Institute. Dr. Shahabi specializes in laparoscopic, robotic and open surgical procedures. Dr. Shahabi believes in a multidisciplinary approach to patient care. This approach has enabled her to deliver outcomes that exceed national benchmarks. Dr. Shahabi is involved in multiple research projects at Albert Einstein College of Medicine and Danbury Hospital and is the author and co-author of numerous publications.
Education:
Medical School
Universite Libre De Bruxelles
Medical School
Yale New Haven Hospital
Medical School
Albert Einstein College Of Medicine
Shohreh Shahabi Photo 2

Shohreh Shahabi

View page
Specialties:
Obstetrics & Gynecology, Gynecologic Oncology
Work:
Northwestern Medical GroupNorthwestern Medical Gynecological Oncology
250 E Superior St FL 4, Chicago, IL 60611
(312) 695-0990 (phone), (312) 472-4706 (fax)
Languages:
English
Description:
Dr. Shahabi works in Chicago, IL and specializes in Obstetrics & Gynecology and Gynecologic Oncology. Dr. Shahabi is affiliated with Northwestern Memorial Hospital and Prentice Womens Hospital.

Resumes

Resumes

Shohreh Shahabi Photo 3

Chief, Division Of Gynecologic Oncology In The Department Of Obstetrics And Gynecology

View page
Location:
Chicago, IL
Industry:
Hospital & Health Care
Work:
Northwestern Memorial Hospital
Chief, Division of Gynecologic Oncology In the Department of Obstetrics and Gynecology

Western Connecticut Health Network 2009 - Apr 2015
Chair, Department of Obstetrics, Gynecology and Reproductive Biology

University of Vermont College of Medicine Jan 2010 - Apr 2015
Clinical Professor, Department of Obstetrics and Gynecology

Yale University School of Medicine Jan 2010 - Apr 2015
Associate Clinical Professor, Department of Obstetrics and Gynecology

Western Connecticut Health Network Jan 2013 - Apr 2015
System Chair, Department of Obstetrics, Gynecology and Reproductive Biology
Skills:
Medical Education
Clinical Research
Gynecologic Oncology
Clinical Trials
Gynecology
Board Certified
Cancer
Healthcare
Medical Research
Da Vinci
Female Cancer
Davinci
Hospitals
Cancer Research
Ovarian Cancer
Translational Research
Public Health
Medicine
Surgery
Healthcare Management
Obstetrics
Internal Medicine
Healthcare Information Technology
Languages:
English
French
Farsi
Certifications:
American Board of Obstetrics and Gynecology: American Board of Obstetrics and Gynecology, Gynecologic Oncology
American Board of Obstetrics and Gynecology
Belgium Board Certification In Obstetrics and Gynecology
France Board of Certification In Obstetrics and Gynecology
Fellow
American College of Obstetricians and Gynecologists
American College of Surgeons

Business Records

Name / Title
Company / Classification
Phones & Addresses
Shohreh Shahabi
Chief Of Obsterics and Gynocology
Hospital The Danbury Inc
Hospital & Medical School Affiliated With Residency · Hospital/Medical Service Plan · Radiology · Specialty Hospital
24 Hospital Ave, Danbury, CT 06810
(203) 739-7000, (203) 797-7066, (203) 797-7213, (203) 797-7640
Shohreh Shahabi
Shohreh Shahabi MD
Oncology · Obgyn
3332 Rochambeau Ave, Bronx, NY 10467
(718) 920-5157

Publications

Us Patents

Method For The Treatment Of Cancer

View page
US Patent:
20120295932, Nov 22, 2012
Filed:
Dec 19, 2011
Appl. No.:
13/329707
Inventors:
Cristiano Ferlini - Rome, IT
Marisa Mariani - Sulmona, IT
Shohreh Shahabi - New York NY, US
Assignee:
Western Connecticut Health Network, Inc. - Danbury CT
International Classification:
A61K 31/437
A61P 35/00
A61K 31/282
C12Q 1/68
G01N 33/574
US Classification:
514283, 435 612, 435 723, 514492
Abstract:
Provided is a method for determining the prognosis of cancer in a female patient with a solid tumor. Also provided is a method of sensitizing a cancer cell from a solid tumor from a male patient other than a prostate cancer cell to treatment with a chemotherapeutic agent comprising administering an effective amount of

Method For The Treatment Of Cancer

View page
US Patent:
20120295878, Nov 22, 2012
Filed:
May 17, 2011
Appl. No.:
13/109128
Inventors:
Cristiano Ferlini - Rome, IT
Marisa Mariani - Sulmona, IT
Shohreh Shahabi - New York NY, US
International Classification:
A61K 31/585
A61K 31/282
A61P 35/00
A61K 31/57
A61K 31/56
A61K 31/4166
G01N 33/574
A61K 31/4745
US Classification:
514171, 435 723, 514492, 514283, 514391
Abstract:
Provided is a method for determining the prognosis of cancer in a female patient with a solid tumor. The percentage of solid tumor cells expressing TUBB3 protein and the percentage of solid tumor cells expressing TUBB6 protein in a solid tumor sample from the patient is determined. Detection of TUBB6 protein expression in a percentage of solid tumor cells of the female patient that is less than the median percentage expression for TUBB6 protein and detection of TUBB3 protein expression in a percentage of solid tumor cells of the female patient that is less than the median percentage expression for TUBB3 protein indicates a patient with good prognosis; and wherein detection of TUBB6 protein expression in a percentage of solid tumor cells of the female patient that is equal to or greater than the median percentage expression for TUBB6 protein and/or detection of TUBB3 protein expression in a percentage of solid tumor cells of the female patient that is equal to or greater than the median percentage expression for TUBB3 protein indicates a patient with poor prognosis. Also provided is a method of sensitizing a cancer cell from a solid tumor from a male patient other than a prostate cancer cell to treatment with a chemotherapeutic agent comprising administering an effective amount of antiandrogen and a chemotherapeutic agent other than an antiandrogen. The antiandrogen may be administered before, after, or at the same time as the chemotherapeutic agent.
Shohreh Shahabi from Pound Ridge, NY, age ~63 Get Report